Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 17, 2020 - Issue 11
Submit an article Journal homepage
271
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells

Yusuf Haggaga Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, Egypt
,
Bayan Abu Rasb School of Pharmacy and Clinical Sciences, University of Bradford, Bradford, UK
,
Yahia El-Tananib School of Pharmacy and Clinical Sciences, University of Bradford, Bradford, UK
,
Murtaza M. Tambuwalac School of Pharmacy and Pharmaceutical Sciences, Ulster University, UKORCID Iconhttps://orcid.org/0000-0001-8499-9891
ORCID Icon,
Paul McCarronc School of Pharmacy and Pharmaceutical Sciences, Ulster University, UK
,
Mohammed Isrebb School of Pharmacy and Clinical Sciences, University of Bradford, Bradford, UK
&
Mohamed El-Tananid Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan;e Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, UKCorrespondence[email protected]
 show all
Pages 1655-1669 | Received 19 May 2020, Accepted 19 Aug 2020, Published online: 15 Sep 2020

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Jingyi Zhou, Kangkang Li, Xinlong Zang, Yi Xie, Jinxiao Song & Xuehong Chen. (2023) ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy. International Journal of Nanomedicine 18, pages 1381-1397.
Read now
Ruijun Ju, Faliang Wu, Yanzhao Tian, Jiahao Chu, Xiaoming Peng & Xiaobo Wang. (2023) Dual Sensitization Anti-Resistant Nanoparticles for Treating Refractory Breast Cancers via Apoptosis-Inducing. Drug Design, Development and Therapy 17, pages 403-418.
Read now
Angelika Długosz-Pokorska, Renata Perlikowska, Tomasz Janecki & Anna Janecka. (2023) New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells. Biologics: Targets and Therapy 17, pages 69-83.
Read now
Ahmed Khaled Abosalha, Waqar Ahmad, Jacqueline Boyajian, Paromita Islam, Merry Ghebretatios, Sabrina Schaly, Rahul Thareja, Karan Arora & Satya Prakash. (2023) A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications. Expert Opinion on Drug Discovery 18:2, pages 149-161.
Read now
Ahmed Khaled Abosalha, Jacqueline Boyajian, Waqar Ahmad, Paromita Islam, Merry Ghebretatios, Sabrina Schaly, Rahul Thareja, Karan Arora & Satya Prakash. (2022) Clinical pharmacology of siRNA therapeutics: current status and future prospects. Expert Review of Clinical Pharmacology 15:11, pages 1327-1341.
Read now
Basak Simitcioglu, Isik Didem Karagoz, Sibel Ilbasmis-Tamer & Ugur Tamer. (2022) Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells. Pharmaceutical Development and Technology 27:7, pages 794-804.
Read now
Xin Yang, Yifan Wang, Si Chen, Shuang Zhang & Chunying Cui. (2021) Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors. International Journal of Nanomedicine 16, pages 7051-7069.
Read now
Yun-Yun Yang, Wei Zhang, Hui Liu, Jun-Jie Jiang, Wen-Jie Wang & Zheng-Yan Jia. (2021) Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer. Drug Design, Development and Therapy 15, pages 4961-4972.
Read now

Articles from other publishers (24)

Hima Sree Buddhiraju, Dokkari Nagalaxmi Yadav, Sreenath Dey, Kalyani Eswar, Ananya Padmakumar & Aravind Kumar Rengan. (2023) Advances in Peptide-Decorated Targeted Drug Delivery: Exploring Therapeutic Potential and Nanocarrier Strategies. ACS Applied Bio Materials.
Crossref
Mariia Stepanova, Alexey Nikiforov, Tatiana Tennikova & Evgenia Korzhikova-Vlakh. (2023) Polypeptide-Based Systems: From Synthesis to Application in Drug Delivery. Pharmaceutics 15:11, pages 2641.
Crossref
Nikolay Zahariev, Plamen Katsarov, Paolina Lukova & Bissera Pilicheva. (2023) Novel Fucoidan Pharmaceutical Formulations and Their Potential Application in Oncology—A Review. Polymers 15:15, pages 3242.
Crossref
Yongxiu Huang, Hongyao Peng, Anqi Zeng & Linjiang Song. (2023) The role of peptides in reversing chemoresistance of breast cancer: current facts and future prospects. Frontiers in Pharmacology 14.
Crossref
Jianing Gong, Taoran Shi, Jinfeng Liu, Zerong Pei, Jingbo Liu, Xiaoliang Ren, Fengyun Li & Feng Qiu. (2023) Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance. Biomedicine & Pharmacotherapy 161, pages 114505.
Crossref
Delaram Kargari Aghmiouni & Sepideh Khoee. (2023) Dual-Drug Delivery by Anisotropic and Uniform Hybrid Nanostructures: A Comparative Study of the Function and Substrate–Drug Interaction Properties. Pharmaceutics 15:4, pages 1214.
Crossref
Yusuf Haggag, Abeer Abd Elrahman, Roland Ulber & Ahmed Zayed. (2023) Fucoidan in Pharmaceutical Formulations: A Comprehensive Review for Smart Drug Delivery Systems. Marine Drugs 21:2, pages 112.
Crossref
Mohamed El-Tanani, Hamdi Nsairat, Vijay Mishra, Yachana Mishra, Alaa A. A. Aljabali, Ángel Serrano-Aroca & Murtaza M. Tambuwala. (2023) Ran GTPase and Its Importance in Cellular Signaling and Malignant Phenotype. International Journal of Molecular Sciences 24:4, pages 3065.
Crossref
Usmani Mohammed Akif, Javed Miyan, Rafquat Rana, Moinuddin, Narayan Kumar Goswami, Tanzeela, Smrati Bhadauria & Manish Kumar Chourasia. (2023) Selective COX-2 Inhibitor Etoricoxib’s Liposomal Formulation Attenuates M2 Polarization of TAMs and Enhances its Anti-metastatic Potential. Pharmaceutical Research 40:2, pages 551-566.
Crossref
Ling Li, Gregory J. Duns, Wubliker Dessie, Zhenmin Cao, Xiaoyuan Ji & Xiaofang Luo. (2023) Recent advances in peptide-based therapeutic strategies for breast cancer treatment. Frontiers in Pharmacology 14.
Crossref
Aliesha Moudgil, Rajesh Salve, Virendra Gajbhiye & Bhushan P. Chaudhari. (2023) Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum. Chemistry and Physics of Lipids 250, pages 105258.
Crossref
Hamed Khodaverdi, Maryam Shokrian Zeini, Mehrdad Moosazadeh Moghaddam, Soheil Vazifedust, Mostafa Akbariqomi & Hamid Tebyaniyan. (2022) Lipid-based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review. Current Drug Delivery 19:10, pages 1012-1033.
Crossref
Qing Tian, Ying Guo, Dan Li & Liang Dong. (2022) Hybrid Gastric Cancer Exosome as Potential Drug Carrier for Targeted Gastric Cancer Therapy. Journal of Biomaterials and Tissue Engineering 12:11, pages 2228-2232.
Crossref
Zhihong Cheng, Yongshuang Li, Duoyi Zhao, Wei Zhao, Meng Wu, Weilin Zhang, Yan Cui, Peng Zhang & Zhiyu Zhang. (2022) Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Hongyan Zhang, Jiandong Yu, Lisha Ma, Yue Zhao, Shujun Xu, Jingbin Shi, Ke Qian, Mancang Gu, Hongsheng Tan, Li Xu, Yun Liu, Chaofeng Mu & Yang Xiong. (2022) Reversing multi-drug resistance by polymeric metformin to enhance antitumor efficacy of chemotherapy. International Journal of Pharmaceutics 624, pages 121931.
Crossref
Sourav Bhattacharjee. (2022) Craft of Co-encapsulation in Nanomedicine: A Struggle To Achieve Synergy through Reciprocity. ACS Pharmacology & Translational Science 5:5, pages 278-298.
Crossref
Mohamed A. Salem, Eman G. Manaa, Nada Osama, Nora M. Aborehab, Mai F. Ragab, Yusuf A. Haggag, Magda T. Ibrahim & Dalia I. Hamdan. (2022) Coriander (Coriandrum sativum L.) essential oil and oil-loaded nano-formulations as an anti-aging potentiality via TGFβ/SMAD pathway. Scientific Reports 12:1.
Crossref
Bakry Ibrahim, Omar Y Mady, Murtaza M Tambuwala & Yusuf A Haggag. (2022) pH-sensitive nanoparticles containing 5-fluorouracil and leucovorin as an improved anti-cancer option for colon cancer. Nanomedicine 17:6, pages 367-381.
Crossref
Yuxiang Deng, Long Yu, Yujie Zhao, Jianhong Peng, Yanbo Xu, JiaYi Qin, Binyi Xiao, Songran Liu, Mei Li, Yujing Fang & Zhizhong Pan. (2021) RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases. Pathology and Oncology Research 27.
Crossref
Cheng Wu, Jiayi Luo, Yuanxin Liu, Jiannan Fan, Xianwen Shang, Riguang Liu, Chuan Ye, Jihong Yang & Hong Cao. (2021) Doxorubicin suppresses chondrocyte differentiation by stimulating ROS production. European Journal of Pharmaceutical Sciences 167, pages 106013.
Crossref
Lu Tang, Jing Li, Qingqing Zhao, Ting Pan, Hui Zhong & Wei Wang. (2021) Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery. Pharmaceutics 13:8, pages 1151.
Crossref
Yusuf A. Haggag, Mohamed Yasser, Murtaza M. Tambuwala, Suleiman S. El Tokhy, Mohammad Isreb & Ahmed A. Donia. (2021) Repurposing of Guanabenz acetate by encapsulation into long-circulating nanopolymersomes for treatment of triple-negative breast cancer. International Journal of Pharmaceutics 600, pages 120532.
Crossref
Moataz B. Zewail, Sanaa A. El-Gizawy, Mohamed A. Osman & Yusuf A. Haggag. (2021) Preparation and In vitro characterization of a novel self-nano emulsifying drug delivery system for a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide. Journal of Drug Delivery Science and Technology 61, pages 102320.
Crossref
Yayan Yang, Qian Feng, Chuanfeng Ding, Wei Kang, Xiufeng Xiao, Yongsheng Yu & Qian Zhou. (2021) Controllable Drug Delivery by Na+/K+ ATPase α1 Targeting Peptide Conjugated DSPE-PEG Nanocarriers for Breast Cancer. Technology in Cancer Research & Treatment 20, pages 153303382110278.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.